Skip to content
BUDGET SAVER — Save $50 on every ELISA kit. Limited-time deal.
Lab Essentials Sale — 50% Off Lab Consumables + Free Shipping.
BIG DEAL — 20% Off Transmembrane Proteins.

Rodent Primary Astrocytes: When to Buy vs. Isolate Your Own

A sourcing decision guide: region, species, donor background and reproducibility — and the cryopreserved lots that fit each case.

?

| July 24, 2026 · 8 Primary astrocytes Mouse & rat astrocytes Region-specific astrocytes GFAP Cryopreserved cells
Rodent Primary Astrocytes: When to Buy vs. Isolate Your Own

Primary astrocytes from mouse and rat can be isolated in almost any lab with a vivarium, so the real sourcing question is not whether you can prep them, but when a cryopreserved lot is the better choice. This application note covers the experiments where the standard shake-off prep does not give you the cells you need, and how to choose region-, species- and disease-matched primary astrocytes instead.

Rodent primary astrocytes are not hard to isolate

Any note that opens by calling primary astrocytes “difficult to obtain” is describing human cells. For mouse and rat the opposite is true — isolation is a well-established, decades-old bench protocol, and much of what the field knows about astrocyte biology came from cultures labs made themselves.

What the standard prep gives you

The classical mixed-glial “shake-off” method dissociates neonatal cortex, grows the mixed culture to confluence over about a week, then separates loosely adherent microglia and oligodendrocyte precursors from the astrocyte monolayer by orbital shaking. Replate the adherent layer and you have astrocytes. The method dates to McCarthy and de Vellis in 1980 and is still the standard route.1

Practically, one cycle runs two to three weeks from pups to usable cells, consumes a litter, and requires an approved animal protocol and vivarium access. What comes out is neonatal cortical astrocytes from whatever strain your facility breeds — and that sentence is the whole decision. If neonatal cortical astrocytes on your house strain answer your question, prep them; it is cheap and it works. Cryopreserved primary astrocytes earn their cost in the cases below, where the prep either cannot produce the cells you need or produces them at a cost that outweighs the saving.

The classical mixed-glial shake-off for primary astrocytes — dissect neonatal cortex, grow to confluence, orbital shake off microglia and OPCs, replate the adherent astrocyte monolayer (McCarthy & de Vellis 1980)
Figure 1. The classical mixed-glial shake-off — dissect neonatal cortex, grow the mixed culture to confluence (~1 week), orbital-shake off microglia and OPCs, then replate the adherent astrocyte monolayer. Roughly two to three weeks per cycle, one litter, and IACUC + vivarium access (McCarthy & de Vellis, 1980).
The classical mixed-glial shake-off for primary astrocytes — dissect neonatal cortex, grow to confluence, orbital shake off microglia and OPCs, replate the adherent astrocyte monolayer (McCarthy & de Vellis 1980) (enlarged)

Five situations where in-house astrocyte isolation breaks down

These are ordered roughly by how often they come up. Note what is not here: if you simply need a different common strain and already run a vivarium, ordering that strain and preparing both sets side by side is usually the easier route.

Prep-versus-buy decision for rodent primary astrocytes — prep if neonatal cortical astrocytes on your house strain answer the question; buy a cryopreserved lot for a non-cortical region, disease-model donor, species you lack, no animal facility, or one lot across a long campaign
Figure 3. The prep-versus-buy decision — if neonatal cortical astrocytes on your house strain answer the question, prep them. If instead you need a non-cortical region, a disease-model donor, a species you don’t house, have no animal facility, or one consistent lot across a long campaign, a cryopreserved lot is the better choice.
Prep-versus-buy decision for rodent primary astrocytes — prep if neonatal cortical astrocytes on your house strain answer the question; buy a cryopreserved lot for a non-cortical region, disease-model donor, species you lack, no animal facility, or one lot across a long campaign (enlarged)

1. You need a CNS region that isn’t cortex

Astrocytes are regionally specialized. Populations from hippocampus, cerebellum, midbrain, brain stem and spinal cord differ in morphology, gene expression and function — inter- and intra-regional diversity is now well documented, and specialized subtypes such as cerebellar Bergmann glia are long-established examples.2 A cortical culture is a poor proxy when your in vivo work sits elsewhere in the neuraxis. The shake-off is built around cortex because cortex yields enough tissue per neonatal pup to be worth dissecting; microdissecting midbrain, brain stem or spinal cord to a usable astrocyte yield takes many more animals and a far more demanding dissection.

Region-matched options:

Region-specific isolates are supplied as custom lots — lot size, package size and marker characterization are confirmed at the point of quote, so the panel and format can be specified to your protocol.

Astrocyte identity varies across the neuraxis — cortex is the standard prep yield, while hippocampus, cerebellum, midbrain, brain stem and spinal cord require region-matched primary astrocyte lots
Figure 2. Astrocyte identity varies across the neuraxis — cortex is what the standard prep yields, but hippocampus, cerebellum, midbrain, brain stem and spinal cord astrocytes differ in morphology, gene expression and function, so a cortical culture is a poor proxy for work elsewhere in the CNS.
Astrocyte identity varies across the neuraxis — cortex is the standard prep yield, while hippocampus, cerebellum, midbrain, brain stem and spinal cord require region-matched primary astrocyte lots (enlarged)

2. You need a disease-model donor

Some questions require astrocytes carrying the disease background itself rather than normal astrocytes exposed to a disease-relevant stimulus. Diabetic donors are the clearest example: cells from a diabetic animal, paired with astrocytes from the matched control background, let you ask whether an astrocytic phenotype is intrinsic to the model or induced by acute treatment. This is the hardest case to reproduce in-house — it means maintaining a disease-model colony and its matched control line, waiting for the phenotypic stage, and running two parallel isolations.

The matched pair: Diabetic Mouse Astrocytes and BKS db Control Mouse Astrocytes, both catalogued in cryopreserved vial and proliferating T25 / T75 flask formats, so the comparison can be run without maintaining either colony.

3. You need a species your facility doesn’t hold

Mouse-focused labs reach for rat when a protocol, an antibody panel or a body of prior literature is rat-based; rat labs reach for mouse when genetic tools are needed. Non-human primate astrocytes serve a different purpose again — a translational checkpoint between rodent findings and human work, particularly for pharmacology and safety readouts. Adding a species means new husbandry, a new IACUC protocol and new dissection expertise for what is often a single comparison arm; non-human primate tissue is not realistically self-sourced at all. Cynomolgus monkey astrocytes and rat astrocytes cover the two most common cross-species arms.

4. You have no animal facility

Contract research organizations, industry screening groups, and bioengineering or microfluidics labs building barrier and organ-chip models routinely need astrocytes without holding an animal protocol. For these groups the question isn’t whether to prep or buy — cryopreserved cells are the only route. The barrier is institutional, not technical: no vivarium, no approved protocol, or a mandate to avoid in-house animal use.

5. You need the same cells across a long campaign

A screening campaign or a multi-month mechanistic series run on repeated fresh preps carries prep-to-prep variability into the dataset. Drawing from banked vials of a single documented lot removes that source of variance and removes the isolation from the critical path — cells are available the week you need them rather than three weeks later. Consolidating onto banked vials also supports reduction under the 3Rs alongside the reproducibility argument.

Where rodent primary astrocytes are used

Across the groups below, the common requirement is a physiologically relevant glial cell with a defined, documented origin — species, region and background all stated, so the culture arm of a study can be reconciled with the animal arm. Browse the full range in the BioHippo cell lines and primary cells catalog.

  • Neuroinflammation & glial signaling — cytokine and chemokine responses, reactive-state characterization, and the astrocytic contribution to CNS inflammatory signaling, alone or in co-culture with neurons or microglia.
  • Neurodegeneration modeling — astrocytic support and dysfunction in Alzheimer’s, Parkinson’s, ALS and related models, including region-matched astrocytes for the affected structure.
  • CNS injury & glial scar — astrogliosis, scar formation and repair biology after mechanical or ischemic insult; spinal cord–derived astrocytes are directly relevant to spinal cord injury work.
  • Blood–brain barrier & the neurovascular unit — astrocytes as a standard component of multicellular barrier models, combined with brain endothelial cells and pericytes in transwell, spheroid or chip formats.
  • Neurotoxicity & CNS safety screening — glial viability, morphology and stress readouts in compound safety assessment, where lot consistency across a screen matters as much as the biology.
  • Metabolic and systemic–CNS interactions — how systemic disease states alter astrocyte phenotype, the use case that drives demand for disease-model donor cells and their matched controls.

What to check before you buy primary astrocytes

Primary cell listings vary widely in how much they disclose. These are the parameters that change experimental design, in the order they usually matter.

Parameter Why it matters
Region of origin Cortex, hippocampus, cerebellum, midbrain, brain stem and spinal cord astrocytes are not interchangeable. Match the region to your in vivo structure.
Species & strain Determines compatibility with your animal model, your antibody panel, and any co-culture partner cells.
Donor age Neonatal and embryonic isolates differ in baseline phenotype and proliferative capacity. Stated donor age belongs in your methods section.
Passage at cryopreservation Cells banked at an early passage leave more usable expansion. A lot shipped at P1 behaves differently from one shipped later.
Expansion capacity How far the lot can be taken before phenotype drifts, stated as additional passages or population doublings. Plan the experiment inside that window.
Identity marker GFAP is the conventional astrocyte marker for these preparations. Confirm it is stated, and consider re-verifying in your own hands.
Sterility & pathogen testing Mycoplasma at minimum; viral and microbial panels where the vendor provides them.
Required medium Primary astrocytes are typically supported by a specified astrocyte medium and supplement. Source it alongside the cells — substituting generic medium is a common cause of poor recovery.
Biosafety level Varies by source material. Confirm it against your institution’s biosafety program before the vials arrive.

Two interpretation caveats worth designing around. First, serum matters: astrocytes in vivo are not normally exposed to serum, and serum-based culture — the basis of the classical method and of most commercially supplied astrocytes — pushes cells toward a reactive phenotype whose gene expression differs from acutely isolated astrocytes; immunopanning into serum-free medium was developed specifically to close that gap.3 This applies equally to cells you prepare yourself, so it is not a purchased-versus-prepped distinction — but serum exposure and passage number belong in your methods, and comparisons should stay within a narrow passage window. Second, purified astrocyte cultures are not automatically free of other glia; where your readout is inflammatory signaling, residual non-astrocytic cells can contribute, so include the controls that let you attribute the response.

Rodent primary astrocytes at BioHippo

The curated range spans two upstream manufacturers — iXCells Biotechnologies and Cell Biologics — covering mouse, rat and non-human primate, with both whole-brain and region-specific isolates. A few representative options:

Cortical and whole-brain isolates, in stock

  • Mouse Astrocytes (MA) — isolated from neonate day-two mouse cerebral cortex, cryopreserved at P1, >0.5 × 106 cells/vial. GFAP-positive; negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. Expandable for 2 additional passages in the manufacturer’s Astrocyte Medium. (BHC18500080 · iXCells Biotechnologies)
  • Rat Astrocytes (RA) — isolated from rat brain, cryopreserved at P1, >0.5 × 106 cells/vial. GFAP-positive; same negative pathogen panel. Expandable for 5 population doublings in the manufacturer’s Astrocyte Medium. (BHC18500102 · iXCells Biotechnologies)

Region-specific isolates, available to order

Mouse and rat astrocytes are available from hippocampus, cerebellum, midbrain, brain stem and spinal cord as custom lots — lot size, package size and marker characterization confirmed at quote.

Disease-model, strain-defined and non-human primate

For disease-model studies, diabetic mouse astrocytes are listed with a matched control counterpart — the pairing that makes an intrinsic-versus-induced comparison possible without maintaining either colony. Strain-defined mouse astrocytes are also catalogued on C57BL/6, BALB/c and CD-1 backgrounds, alongside rat and cynomolgus monkey astrocytes, in cryopreserved vial and proliferating T25 / T75 flask formats.

Specifications vary by manufacturer and lot. Confirm donor age, passage, characterization and required medium on the individual product page and datasheet before purchase. Browse everything in one place: primary astrocytes at BioHippo, or request a quote for a custom region or background.

Frequently asked questions

Should I buy or isolate primary astrocytes?

If neonatal cortical astrocytes on the strain your facility already breeds answer your question, isolating them with the McCarthy–de Vellis shake-off is cheap and reliable. Buy cryopreserved primary astrocytes when you need a non-cortical CNS region, a disease-model or matched-control background, a species you don’t house, when you have no animal facility, or when a long campaign needs one consistent lot.

What marker identifies primary astrocytes?

GFAP (glial fibrillary acidic protein) is the conventional identity marker for these preparations. Confirm the vendor states GFAP positivity, and consider re-verifying it in your own hands, since GFAP expression varies with region and reactive state.

Are region-specific astrocytes such as hippocampal or spinal cord available off the shelf?

Whole-brain/cortical mouse and rat astrocytes are stocked; hippocampal, cerebellar, midbrain, brain stem and spinal cord isolates are supplied as custom lots, with lot size, package size and marker characterization confirmed at quote.

Why does serum matter for astrocyte cultures?

Astrocytes in vivo are not normally exposed to serum. Serum-based culture pushes them toward a reactive phenotype whose gene expression differs from acutely isolated astrocytes, which is why serum-free immunopanning was developed.3 Record serum exposure and passage number in your methods and keep comparisons within a narrow passage window.

Can I get disease-model astrocytes with matched controls?

Yes — diabetic mouse astrocytes are catalogued alongside a BKS db control line, so an intrinsic-versus-induced comparison can be run without maintaining either colony.

References

  1. McCarthy KD, de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol. 1980;85(3):890–902. doi:10.1083/jcb.85.3.890 · PMID 6248568
  2. Ben Haim L, Rowitch DH. Functional diversity of astrocytes in neural circuit regulation. Nat Rev Neurosci. 2017;18(1):31–41. doi:10.1038/nrn.2016.159 · PMID 27904142
  3. Foo LC, Allen NJ, Bushong EA, et al. Development of a method for the purification and culture of rodent astrocytes. Neuron. 2011;71(5):799–811. doi:10.1016/j.neuron.2011.07.022 · PMID 21903074

All products referenced are for Research Use Only. Not for use in diagnostic or therapeutic procedures. Product specifications are drawn from the corresponding manufacturer records on ebiohippo.com; iXCells Biotechnologies and Cell Biologics Inc. are the manufacturers of the products referenced.


Featured Products

Mouse Astrocytes (MA) – Figure 1 of 1
Mouse Astrocytes (MA)
BHC18500080View product →
Rat Astrocytes (RA) – Figure 1 of 1
Rat Astrocytes (RA)
BHC18500102View product →
No image
Diabetic Mouse Astrocytes
BHC16406393View product →
No image
BKS db Control Mouse Astrocytes
BHC16406382View product →
No image
Monkey Astrocytes
BHC16406678View product →

Shop Related Collections



Ask a Scientist →